European Falsified Medicine Directive (FMD)
If you distribute pharmaceuticals in Europe, you are likely aware that the European Falsified Medicine Directive (FMD) (2011/62/EU) takes effect on February 9, 2019. According to the European Commission, this directive, “helps manufacturers, wholesalers and logistics service providers within the pharmaceutical industry fight counterfeit medicines to improve patient safety.” One of the regulations is to include, “obligatory safety features – a unique identifier and an anti-tampering device,” on the outer packaging of medicines. While this may seem like a daunting task, the regulation will improve pharmaceutical inventory processes and prevent defective medication from being distributed to consumers.
How to Comply with FMD
In order to comply with the European Falsified Medicine Directive (FMD), it is crucial that you select the best inventory tool to reduce errors and properly track your pharmaceuticals. TRXio’s inventory scanning system can help you become FMD compliant through live a QR-code technology that monitors millions (billions) of individual inventory items.
TRXio offers a traceability aspect that many other solutions lack since it has the ability to track the movement of an individual item from its origin to the end of its useful life. This provides valuable knowledge of who comes into contact with the item along the way and allows distributors to track individual products by expiration date, lot number, etc.